229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.84%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-1.12%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.35%
EBIT growth below 50% of VUZI's 11.13%. Michael Burry would suspect deeper competitive or cost structure issues.
1.35%
Operating income growth under 50% of VUZI's 10.47%. Michael Burry would be concerned about deeper cost or sales issues.
-26.98%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-29.03%
Negative EPS growth while VUZI is at 9.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-26.67%
Negative diluted EPS growth while VUZI is at 9.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.80%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.59%
Diluted share count expanding well above VUZI's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-72.15%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-85.14%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-40.15%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-6.85%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
26.37%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
333.64%
10Y OCF/share CAGR above 1.5x VUZI's 60.75%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-83.07%
Negative 5Y OCF/share CAGR while VUZI is at 51.30%. Joel Greenblatt would question the firm’s operational model or cost structure.
231.33%
3Y OCF/share CAGR above 1.5x VUZI's 12.89%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
76.19%
Net income/share CAGR above 1.5x VUZI's 33.50% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-74.56%
Negative 5Y net income/share CAGR while VUZI is 14.04%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
1.34%
Below 50% of VUZI's 36.24%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
38.62%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
54.11%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
13.78%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while VUZI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.17%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-29.21%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-3.39%
Negative asset growth while VUZI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.87%
Similar to VUZI's 2.76%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-100.00%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
3.36%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
0.58%
We expand SG&A while VUZI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.
